• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jade Biosciences, Inc. - Common Stock (NQ:JBIO)

    8.980 -0.110 (-1.21%)
    Streaming Delayed Price Updated: 11:24 AM EDT, Oct 14, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 48,163
    Open 8.950
    Bid (Size) 8.950 (2)
    Ask (Size) 9.060 (1)
    Prev. Close 9.090
    Today's Range 8.880 - 9.130
    52wk Range 6.565 - 13.50
    Shares Outstanding 28,985,019
    Dividend Yield 26.73%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences Announces $135 Million Private Placement
    From Jade Biosciences
    Via GlobeNewswire

    Performance

    YTD
    -11.4%
    -11.4%
    1 Month
    +27.0%
    +27.0%
    3 Month
    -0.2%
    -0.2%
    6 Month
    -11.4%
    -11.4%
    1 Year
    -11.4%
    -11.4%

    More News

    Read More
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences to Participate in Upcoming Conferences
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences Posts Wider Loss in Q2
    Via The Motley Fool
    Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
    From Jade Biosciences
    Via GlobeNewswire
    Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Jade Biosciences to Participate in Two Upcoming Investor Conferences
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
    From Jade Biosciences
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
    From Jade Biosciences
    Via GlobeNewswire
    Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference
    From Jade Biosciences
    Via GlobeNewswire
    Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Frequently Asked Questions

    Is Jade Biosciences, Inc. - Common Stock publicly traded?
    Yes, Jade Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Jade Biosciences, Inc. - Common Stock trade on?
    Jade Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Jade Biosciences, Inc. - Common Stock?
    The ticker symbol for Jade Biosciences, Inc. - Common Stock is JBIO on the Nasdaq Stock Market
    What is the current price of Jade Biosciences, Inc. - Common Stock?
    The current price of Jade Biosciences, Inc. - Common Stock is 8.980
    When was Jade Biosciences, Inc. - Common Stock last traded?
    The last trade of Jade Biosciences, Inc. - Common Stock was at 10/14/25 11:24 AM ET
    What is the market capitalization of Jade Biosciences, Inc. - Common Stock?
    The market capitalization of Jade Biosciences, Inc. - Common Stock is 260.29M
    How many shares of Jade Biosciences, Inc. - Common Stock are outstanding?
    Jade Biosciences, Inc. - Common Stock has 260M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.